178 related articles for article (PubMed ID: 3386367)
1. [Oncogenes in squamous epithelial cancers in the area of the head and neck].
Volling P; Jungehülsing M; Tesch H; Stennert E
Laryngol Rhinol Otol (Stuttg); 1988 Apr; 67(4):160-4. PubMed ID: 3386367
[TBL] [Abstract][Full Text] [Related]
2. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
Somers KD; Cartwright SL; Schechter GL
Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
[TBL] [Abstract][Full Text] [Related]
3. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of oncogene expression in head and neck tumours.
Field JK; Lamothe A; Spandidos DA
Anticancer Res; 1986; 6(4):595-600. PubMed ID: 3019219
[TBL] [Abstract][Full Text] [Related]
5. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.
Berenson JR; Yang J; Mickel RA
Oncogene; 1989 Sep; 4(9):1111-6. PubMed ID: 2476705
[TBL] [Abstract][Full Text] [Related]
6. [Detection of 8 oncogenes in squamous epithelial cancers of the head and neck].
Jungehülsing M; Volling P
HNO; 1994 May; 42(5):280-7. PubMed ID: 8050916
[TBL] [Abstract][Full Text] [Related]
7. Oncogenes in head and neck cancer.
Irish JC; Bernstein A
Laryngoscope; 1993 Jan; 103(1 Pt 1):42-52. PubMed ID: 8421418
[TBL] [Abstract][Full Text] [Related]
8. MYC gene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients.
Bhattacharya N; Roy A; Roy B; Roychoudhury S; Panda CK
J Oral Pathol Med; 2009 Nov; 38(10):759-63. PubMed ID: 19453846
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma.
Field JK; Spandidos DA; Stell PM; Vaughan ED; Evan GI; Moore JP
Oncogene; 1989 Dec; 4(12):1463-8. PubMed ID: 2687767
[TBL] [Abstract][Full Text] [Related]
10. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
11. [Oncogenic activity of head and neck tumors].
Basterra J; Armengot M; Martorell M; Barona R; Montalt J
An Otorrinolaringol Ibero Am; 1995; 22(2):197-206. PubMed ID: 7778721
[TBL] [Abstract][Full Text] [Related]
12. C-myc gene amplification in different stages of oesophageal squamous cell carcinoma: prognostic value in relation to treatment modality.
Bitzer M; Stahl M; Arjumand J; Rees M; Klump B; Heep H; Gabbert HE; Sarbia M
Anticancer Res; 2003; 23(2B):1489-93. PubMed ID: 12820414
[TBL] [Abstract][Full Text] [Related]
13. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
Freier K; Joos S; Flechtenmacher C; Devens F; Benner A; Bosch FX; Lichter P; Hofele C
Cancer Res; 2003 Mar; 63(6):1179-82. PubMed ID: 12649172
[TBL] [Abstract][Full Text] [Related]
14. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
[TBL] [Abstract][Full Text] [Related]
15. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
[TBL] [Abstract][Full Text] [Related]
16. Amplification of human int-2 in breast cancers and squamous carcinomas.
Zhou DJ; Casey G; Cline MJ
Oncogene; 1988 Mar; 2(3):279-82. PubMed ID: 2895446
[TBL] [Abstract][Full Text] [Related]
17. Approximately 580 Kb surrounding the MYC gene is amplified in head and neck squamous cell carcinoma of Indian patients.
Bhattacharya N; Sabbir MG; Roy A; Dam A; Roychoudhury S; Panda CK
Pathol Res Pract; 2005; 201(10):691-7. PubMed ID: 16325511
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes.
Yokota J; Wada M; Yoshida T; Noguchi M; Terasaki T; Shimosato Y; Sugimura T; Terada M
Oncogene; 1988 Jun; 2(6):607-11. PubMed ID: 2838790
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas.
Waitzberg AF; Nonogaki S; Nishimoto IN; Kowalski LP; Miguel RE; Brentani RR; Brentani MM
Cancer Detect Prev; 2004; 28(3):178-86. PubMed ID: 15225897
[TBL] [Abstract][Full Text] [Related]
20. Head and neck squamous cell carcinoma cell lines as a model system for the study of oncogene expression during tumor progression and metastasis.
Gallick GE; Sacks PG; Maxwell SA; Steck PA; Gutterman JU
Prog Clin Biol Res; 1986; 212():97-111. PubMed ID: 3012576
[No Abstract] [Full Text] [Related]
[Next] [New Search]
